Total properties:
23
|
|
Patent #:
|
|
Issue Dt:
|
11/01/2011
|
Application #:
|
11912545
|
Filing Dt:
|
10/25/2007
|
Publication #:
|
|
Pub Dt:
|
08/14/2008
| | | | |
Title:
|
PYRIMIDINE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2013
|
Application #:
|
12310801
|
Filing Dt:
|
09/30/2009
|
Publication #:
|
|
Pub Dt:
|
03/11/2010
| | | | |
Title:
|
PYRIDIN-4-YL DERIVATIVES AS IMMUNOMODULATING AGENTS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/10/2012
|
Application #:
|
12445352
|
Filing Dt:
|
04/13/2009
|
Publication #:
|
|
Pub Dt:
|
02/11/2010
| | | | |
Title:
|
2-AMINOCARBONYL-PYRIDINE DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/25/2011
|
Application #:
|
12447039
|
Filing Dt:
|
04/24/2009
|
Publication #:
|
|
Pub Dt:
|
11/26/2009
| | | | |
Title:
|
2-PHENYL-6-AMINOCARBONYL-PYRIMIDINE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2013
|
Application #:
|
12745358
|
Filing Dt:
|
05/28/2010
|
Publication #:
|
|
Pub Dt:
|
10/14/2010
| | | | |
Title:
|
PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS
|
|
|
Patent #:
|
|
Issue Dt:
|
11/05/2013
|
Application #:
|
12920656
|
Filing Dt:
|
09/02/2010
|
Publication #:
|
|
Pub Dt:
|
12/30/2010
| | | | |
Title:
|
PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATING AGENTS
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2011
|
Application #:
|
12936661
|
Filing Dt:
|
10/06/2010
|
Publication #:
|
|
Pub Dt:
|
02/24/2011
| | | | |
Title:
|
SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
06/18/2013
|
Application #:
|
12936664
|
Filing Dt:
|
10/06/2010
|
Publication #:
|
|
Pub Dt:
|
02/03/2011
| | | | |
Title:
|
2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/16/2012
|
Application #:
|
13263089
|
Filing Dt:
|
10/06/2011
|
Publication #:
|
|
Pub Dt:
|
02/02/2012
| | | | |
Title:
|
6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES
|
|
|
Patent #:
|
|
Issue Dt:
|
03/04/2014
|
Application #:
|
13265493
|
Filing Dt:
|
10/20/2011
|
Publication #:
|
|
Pub Dt:
|
10/24/2013
| | | | |
Title:
|
THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS
|
|
|
Patent #:
|
|
Issue Dt:
|
02/25/2014
|
Application #:
|
13383619
|
Filing Dt:
|
01/12/2012
|
Publication #:
|
|
Pub Dt:
|
05/03/2012
| | | | |
Title:
|
PYRIDIN-4-YL DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
09/15/2015
|
Application #:
|
13980764
|
Filing Dt:
|
07/19/2013
|
Publication #:
|
|
Pub Dt:
|
11/14/2013
| | | | |
Title:
|
2-METHOXY-PYRIDIN-4-YL-DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
04/11/2017
|
Application #:
|
14777444
|
Filing Dt:
|
09/15/2015
|
Title:
|
PYRIDIN-4-YL DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/20/2019
|
Application #:
|
15575332
|
Filing Dt:
|
11/17/2017
|
Publication #:
|
|
Pub Dt:
|
05/24/2018
| | | | |
Title:
|
CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
|
|
|
Patent #:
|
|
Issue Dt:
|
08/04/2020
|
Application #:
|
16335973
|
Filing Dt:
|
03/22/2019
|
Publication #:
|
|
Pub Dt:
|
01/16/2020
| | | | |
Title:
|
CRYSTALLINE FORMS
|
|
|
Patent #:
|
|
Issue Dt:
|
11/23/2021
|
Application #:
|
16494254
|
Filing Dt:
|
09/13/2019
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
Title:
|
SUBCUTANEOUS ADMINISTRATION OF A P2Y12 RECEPTOR ANTAGONIST
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2020
|
Application #:
|
16503245
|
Filing Dt:
|
07/03/2019
|
Publication #:
|
|
Pub Dt:
|
10/24/2019
| | | | |
Title:
|
CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
|
|
|
Patent #:
|
|
Issue Dt:
|
06/21/2022
|
Application #:
|
16938730
|
Filing Dt:
|
07/24/2020
|
Publication #:
|
|
Pub Dt:
|
01/14/2021
| | | | |
Title:
|
CRYSTALLINE FORMS
|
|
|
Patent #:
|
|
Issue Dt:
|
07/19/2022
|
Application #:
|
17070876
|
Filing Dt:
|
10/14/2020
|
Publication #:
|
|
Pub Dt:
|
01/28/2021
| | | | |
Title:
|
CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
|
|
|
Patent #:
|
|
Issue Dt:
|
02/18/2025
|
Application #:
|
17741427
|
Filing Dt:
|
05/10/2022
|
Publication #:
|
|
Pub Dt:
|
09/01/2022
| | | | |
Title:
|
CRYSTALLINE FORMS
|
|
|
Patent #:
|
|
Issue Dt:
|
12/05/2023
|
Application #:
|
17810545
|
Filing Dt:
|
07/01/2022
|
Publication #:
|
|
Pub Dt:
|
01/05/2023
| | | | |
Title:
|
CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18016299
|
Filing Dt:
|
01/13/2023
|
Publication #:
|
|
Pub Dt:
|
08/17/2023
| | | | |
Title:
|
AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTAGONIST
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18579110
|
Filing Dt:
|
01/12/2024
|
Publication #:
|
|
Pub Dt:
|
09/26/2024
| | | | |
Title:
|
PROCESS FOR THE SYNTHESIS OF 4-((R)-2-{[6-((S)-3-METHOXY-PYRROLIDIN-1-YL)-2-PHENYL-PYRIMIDINE-4-CARBONYL]-AMINO}-3-PHOSPHONO-PROPIONYL)-PIPERAZINE-1-CARBOXYLIC ACID BUTYL ESTER
|
|